Related Experiment Video
Updated: May 24, 2026

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Drugs and AKI
1Klinikum Coburg, III. Med. Klinik, Coburg, Germany. liangos_o@hotmail.com
Abstract:
Acute kidney injury is a common complication in hospitalized patients and is associated with substantially increased morbidity and mortality. Frequently, it is caused by impaired renal perfusion, ischemia and reperfusion injury, sepsis or urinary tract obstruction, but often its etiology is multifactorial. In this context, the contribution of nephrotoxic medications to the development of AKI plays an important role. This review begins with an attempt to evaluate the importance of drug-related acute kidney injury in general. Then, a selected list of 7 classes of drugs or compounds, namely aminoglycosides, aristolochic acid, cytostatic drugs, nonsteroidal anti-inflammatory drugs, osmotic agents, radiocontrast, and phosphate salts are discussed in depth, including their epidemiology, pathophysiology, clinical features and treatment. While not attempting to be exhaustive, this review attempts to provide an overview with additional in-depth information on certain classes of drugs that are either of general importance or have recently emerged in the literature.
Insights
Drug-induced acute kidney injury (AKI) is a significant concern in hospitalized patients. This review details the role of various medications, including aminoglycosides and NSAIDs, in causing AKI.
Area of Science:
- Nephrology
- Pharmacology
- Internal Medicine
Background:
- Acute kidney injury (AKI) is a frequent complication in hospitalized patients, significantly increasing morbidity and mortality.
- Common causes include impaired renal perfusion, ischemia-reperfusion injury, sepsis, and urinary tract obstruction, often with multifactorial etiology.
- Nephrotoxic medications play a crucial role in the development of AKI.
Purpose of the Study:
- To evaluate the general importance of drug-related acute kidney injury.
- To provide an in-depth review of specific drug classes implicated in AKI.
- To offer an overview of drug-induced AKI, highlighting recently emerged or generally important agents.
Main Methods:
- Review of existing literature on drug-induced acute kidney injury.
- Selection and in-depth discussion of seven key drug classes: aminoglycosides, aristolochic acid, cytostatic drugs, nonsteroidal anti-inflammatory drugs (NSAIDs), osmotic agents, radiocontrast, and phosphate salts.
- Analysis of epidemiology, pathophysiology, clinical features, and treatment for each selected drug class.
Main Results:
- Drug-induced AKI is a significant contributor to overall AKI incidence in hospitalized populations.
- Detailed insights into the mechanisms, clinical presentation, and management strategies for specific nephrotoxic agents were provided.
- The review emphasizes the clinical relevance of understanding drug-induced nephrotoxicity.
Conclusions:
- Nephrotoxic medications are an important, often overlooked, cause of acute kidney injury.
- Understanding the specific properties of drugs like NSAIDs and aminoglycosides is critical for prevention and management.
- This review provides a valuable resource for clinicians managing patients at risk of drug-induced AKI.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pharmacokinetics: Drug–Drug Interactions
Drug toxicity: Drug–Drug Interaction
Drug Toxicity: Risk factors
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Acute Kidney Injury V: Interprofessional Care
